Medical Device News Magazine

Palm Beach Gardens Medical Center Earns Blue Distinction® Center+ Designation for Quality and Cost-Efficiency in Knee and Hip Replacement Surgeries

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Blue Cross and Blue Shield Association [BCBSA] selects Palm Beach Gardens Medical Center as a Blue Distinction Center+ for Knee and Hip Replacement, part of the Blue Distinction Specialty Care program.

Blue Distinction Centers are nationally designated healthcare facilities that show a commitment to delivering high-quality patient safety and better health outcomes, based on objective measures that were developed with input from the medical community and leading accreditation and quality organizations.

“Palm Beach Gardens Medical Center is proud to be recognized by BCBSA for meeting the robust selection criteria for knee and hip replacements set by the Blue Distinction Specialty Care program”, said Teresa Urquhart, chief executive officer for Palm Beach Gardens Medical Center. “This designation is a testament to the hard work and dedication our orthopedic medical staff provides to each patient who is treated at our hospital. We could not be more grateful for this accomplishment.”

Facilities designated as Blue Distinction Centers® for Knee and Hip Replacement demonstrate expertise in total knee and total hip replacement surgeries, resulting in fewer patient complications and hospital readmissions. Designated facilities include hospitals (with and without an onsite Intensive Care Unit) and Ambulatory Surgery Centers (ASC).

All designated facilities must maintain national accreditation, and ASCs are also required to have an advanced orthopedic certification. In addition to meeting these quality thresholds, hospitals designated as Blue Distinction Centers+ are on average 20 percent more cost-efficient in an episode of care compared to other facilities. Quality is key: only those facilities that first meet nationally established, objective quality measures will be considered for designation as a Blue Distinction Center+.

For more information about our orthopedics program and services, go to www.pbgmc.com/services/orthopedics or call 561-622-1411.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Ultrahuman Announces its App Store ‘PowerPlugs’ with the World’s First AFib Detection Technology on a Smart Ring

Recognizing each individual’s health journey is unique, PowerPlugs enable people to choose and focus on the aspects of their health that matter most. It’s designed for highly personalized health insights, ensuring that every individual can personalize their health tracking to their unique needs and goals.

VisionAir Solutions Celebrates Milestone and New Collaboration

This achievement marks VisionAir Solutions commitment to bringing technological innovation to pulmonary medicine. Since its acquisition by Theken Companies last year, VAS has over doubled its growth and continues to demonstrate industry adoption and the advantages of personalized healthcare.

ArisGlobal Reports | Newest Version of LifeSphere® Regulatory Platform Launches

Ann-Marie Orange, CIO & Global Head of R&D shares, “With more than 35 years of experience in life sciences technology, ArisGlobal is the only technology company offering strong Safety, Regulatory, and Quality Management solutions powered with next-generation cognitive computing, delivering unmatched interoperability across the R&D IT ecosystem. Over the last 18 months ArisGlobal has made significant investment in the strategic acquisitions of Amplexor Life Sciences and SPORIFY, along with technology R&D – and we’re not stopping.”